![Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00535-021-01784-1/MediaObjects/535_2021_1784_Fig3_HTML.png)
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
![Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax](https://abivax.gcs-web.com/sites/g/files/knoqqb87736/themes/site/client_site/dist/images/abivax-ir-banner.jpg)
Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn's and Colitis Organisation (ECCO) | Abivax
![Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00535-021-01784-1/MediaObjects/535_2021_1784_Fig2_HTML.png)
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 | Journal of Gastroenterology
![Dr. David Rubin Discusses Initial Results of Takeda-Sponsored and Litmus-Powered Research at DDW | by Litmus Health | The Litmus Papers | Medium Dr. David Rubin Discusses Initial Results of Takeda-Sponsored and Litmus-Powered Research at DDW | by Litmus Health | The Litmus Papers | Medium](https://cdn-images-1.medium.com/fit/t/1600/480/1*hVDJ8Kgn8GiwKbvMnLM0Og.png)
Dr. David Rubin Discusses Initial Results of Takeda-Sponsored and Litmus-Powered Research at DDW | by Litmus Health | The Litmus Papers | Medium
![European Crohn´s and Colitis Organisation - ECCO - ECCO News Editors' Summary of the ECCO'19 Scientific Programme European Crohn´s and Colitis Organisation - ECCO - ECCO News Editors' Summary of the ECCO'19 Scientific Programme](https://www.ecco-ibd.eu/images/2_Congresses_Events/2019/5_Gallery_Copenhagen/General_Impressions/Thu-156.jpg)
European Crohn´s and Colitis Organisation - ECCO - ECCO News Editors' Summary of the ECCO'19 Scientific Programme
![JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products](https://pub.mdpi-res.com/jcm/jcm-09-01273/article_deploy/html/images/jcm-09-01273-g003.png?1588092886)
JCM | Free Full-Text | Revisiting Inflammatory Bowel Disease: Pathology, Treatments, Challenges and Emerging Therapeutics Including Drug Leads from Natural Products
![Entyvio® superior to Humira® in first head-to-head biologic clinical study in ulcerative colitis - The Evidence Base Entyvio® superior to Humira® in first head-to-head biologic clinical study in ulcerative colitis - The Evidence Base](https://www.evidencebaseonline.com/wp-content/uploads/2020/07/4ee644f6-32eb-4b33-85e1-783c706ad6a8-5f07184761f8d-scaled-800x345.jpg)
Entyvio® superior to Humira® in first head-to-head biologic clinical study in ulcerative colitis - The Evidence Base
![Defining the Future of IBD Care: The Pivotal Role of Personalized Treatment” – ECCO 2019 - European Medical Journal Defining the Future of IBD Care: The Pivotal Role of Personalized Treatment” – ECCO 2019 - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2019/04/Defining-the-Future-of-IBD-Care....jpg)